rs1041981 — LTA Thr26Asn (TNFB*2)

LTA Thr26Asn — When a Cytokine Blueprint Shifts Innate Defense

Lymphotoxin-alpha (LTα)¹¹ Lymphotoxin-alpha (LTα)
a homotrimeric or heterotrimeric cytokine of the TNF superfamily, secreted mainly by activated lymphocytes and NK cells is one of the founding members of the immune signaling family that includes TNF itself. Unlike TNF, which is broadly expressed by macrophages and adipocytes, LTα is produced predominantly by lymphocytes and has a distinct but overlapping set of receptors and biological roles. Its two receptors — TNFR1 and TNFR2 — are shared with TNF, but LTα also forms heterotrimers with lymphotoxin-beta (LTβ) to activate the LTβ receptor, which directs lymphoid organogenesis. LTα is essential for the normal development of lymph nodes, Peyer's patches, and other secondary lymphoid structures, and it drives innate immune responses against bacteria, viruses, and transformed cells.

The rs1041981 variant — historically called the TNFB*2 allele — substitutes asparagine for threonine at position 26 of the mature protein (position 60 in the precursor, after a 34-residue signal peptide is cleaved). This change falls in the N-terminal "stalk" region of the LTα subunit, which is involved in receptor binding and trimer stability, and the A allele frequency is approximately 35% globally²² A allele frequency is approximately 35% globally, making it one of the more common functional variants in the TNF/LTA chromosomal region at 6p21.33.

The Mechanism

LTα is synthesized as a 205-amino-acid precursor. After signal peptide cleavage at position 34, the mature 171-amino-acid protein assembles into trimers that bind TNFR1 and TNFR2. The Thr26Asn change (mature protein numbering) introduces an asparagine in a region that contacts receptor ectodomains. UniProt annotation (P01374) classifies this as a natural variant at precursor position 60³³ UniProt annotation (P01374) classifies this as a natural variant at precursor position 60, confirming the Asn substitution occurs in the trimer's receptor-binding interface area. The biological consequence is subtle rather than ablative — LTα-Asn26 is secreted normally and retains signaling function, but may alter binding affinity to TNFR1/TNFR2, modestly shifting the inflammatory set-point of cells responding to LTα. The rs1041981 A allele is in strong linkage disequilibrium with the adjacent intron variant rs909253 (r² ~0.92 in European populations), meaning the two frequently travel together on the same TNFB*2 haplotype block and their independent effects are difficult to fully disentangle.

The Evidence

The most quantitatively robust finding is in cancer susceptibility. A 2013 meta-analysis of 30 case-control studies covering 58,649 participants⁴⁴ 2013 meta-analysis of 30 case-control studies covering 58,649 participants
Huang et al., PLoS One found that the rs1041981 A allele conferred a statistically significant 15% elevation in cancer risk (OR 1.15, 99% CI 1.07–1.25, p < 0.0001). The association was seen across multiple cancer types, consistent with LTα's broad role in tumor immune surveillance through TNFR-mediated apoptosis and lymphocyte recruitment to tumor sites. A more targeted study in hepatocellular carcinoma (Alhelf et al., 2023, n = 317)⁵⁵ (Alhelf et al., 2023, n = 317) confirmed the A allele was independently associated with HCC risk in an Egyptian case-control study.

In the cardiovascular domain, results are mixed. A 2012 autopsy study of 1,503 consecutive cases⁶⁶ 2012 autopsy study of 1,503 consecutive cases
Ikeda et al., Atherosclerosis found that AA + CA carriers had significantly greater coronary stenosis severity than CC homozygotes (OR 1.54, 95% CI 1.17–2.01), a pathological measure of subclinical atherosclerotic burden. However, the large ISIS case-control study of 6,928 MI cases⁷⁷ ISIS case-control study of 6,928 MI cases
Clarke et al., PLoS Genetics 2006 found no significant association between LTA variants including rs1041981 and myocardial infarction occurrence, though higher CRP levels were seen in certain LTA haplotypes. This pattern — subclinical atherosclerosis association without a clear MI event signal — suggests rs1041981 may influence arterial inflammation and plaque development without necessarily precipitating acute coronary events.

For infectious disease, a 2017 study of Inuit populations⁸⁸ 2017 study of Inuit populations
Song et al., Scientific Reports found the A allele significantly associated with bronchitis risk, with the magnitude of risk modified by environment (westernized vs. rural lifestyle). A family-based analysis of 160 trio families⁹⁹ family-based analysis of 160 trio families
Boraska et al., Human Immunology 2009 found significant overtransmission of the A allele to type 1 diabetes-affected offspring (p = 1.1×10⁻⁴), consistent with LTα's established role in pancreatic islet inflammation. The variant also sits within the same LTA/TNF haplotype block studied extensively for autoimmune diseases including rheumatoid arthritis, celiac disease, and multiple sclerosis, though rs1041981 itself is primarily a tag SNP for this region rather than the primary functional driver in all contexts.

Practical Actions

The rs1041981 A allele operates as a moderate risk modifier across several domains — cancer surveillance, subclinical atherosclerosis, and respiratory infection vulnerability — rather than a single-disease variant. Its effect size in each domain is modest (OR ~1.15–1.54 depending on the outcome), which means it does not warrant alarm but does point to specific monitoring strategies that can reduce the probability of adverse outcomes.

For A allele carriers, the most actionable implications relate to cancer screening adherence, cardiovascular inflammation monitoring, and attention to respiratory health. LTα's role in lymphoid tissue development and tumor immune surveillance means the A allele's modest risk operates through immune-modulating pathways rather than direct mutagenesis.

Interactions

The rs1041981 A allele resides within the classic HLA class III region¹⁰¹⁰ HLA class III region
a gene-dense segment of chromosome 6p21.33 housing TNF, LTA, and numerous immune-regulatory genes in strong LD. The adjacent intronic variant rs909253¹¹¹¹ rs909253
a commonly studied LTA intronic SNP in the same TNFB haplotype block travels with rs1041981 in ~92% of European haplotypes. The TNF promoter variant rs1800629¹²¹² rs1800629
TNF -308 G>A, the most studied TNF pathway polymorphism is in the same chromosomal neighborhood and occasionally studied in combined haplotype analyses with LTA variants. A combined LTA/TNF haplotype carrying both inflammatory alleles may produce additive effects on cytokine tone, though published compound analyses are limited for this specific pair.